American Gastroenterological Association (AGA)

12/24/2025

While federal $$$ for medical research is falling short, the AGA Research Foundation is committed to being the bridge for innovative GI research. In 2025 alone, we awarded $2.4 million in research funding and added $400,000 in pilot awards to support researchers at risk of losing momentum due to federal cuts.

We are called to fund even more GI researchers in 2026, but we need your help. Please consider a gift to the AGA Research Foundation this holiday season. Your gift is 100% tax deductible: https://ow.ly/Frt450XMynL

12/23/2025

What was new in GI care for 2025?

Our latest clinical guidelines and practice updates cover everything from IBD screening and vaccination to Crohn’s disease treatment, gastroparesis care, and more.

Explore expert guidance, practical resources, and tools designed to support evidence-based, high-quality patient care.
🔗 https://ow.ly/UBzh50XNRwS

12/23/2025

Season’s greetings! ❄️

We’re reflecting on 2025 in gratitude: from awarding the inaugural Beacon of Hope Awards to deserving women in GI during Digestive Disease Week® (DDW®) to walking the halls of Congress during Advocacy Day as we fight to affect positive change for GI care. We all came together to make a difference: researchers, clinicians, APPs, and fellows from all walks of life.

We wish you and yours a wonderful and restful holiday season and a happy new year ahead.

AGA's office will be closed Dec. 25, 2025-Jan. 1, 2026, for the holidays. The AGA GI Patient Center (patient.gastro.org) is always available to answer questions about digestive health conditions.

12/18/2025

New guidance is available for clinicians managing patients with cirrhosis.

Our new clinical practice update reviews the evidence and provides 13 tips for managing ascites, hepatic hydrothorax, volume overload, and hyponatremia, and identifies key areas for future research.

Read more here: https://ow.ly/s02e50XLcex

12/11/2025

📢 New clinical practice update
Advances in endoscopic techniques are reshaping how clinicians manage early (T1) colorectal cancer. ✨

Key insights:
☑️ Management must balance metastasis risk with surgical morbidity
☑️ Current histologic criteria are imperfect — most “high-risk” cases show no nodal disease
☑️ En-bloc resection via ESD may be diagnostic and potentially curative
☑️ EFTR may be an alternative when ESD is not feasible
☑️ More research is needed to refine selection criteria and improve predictive models

Read more here: https://ow.ly/HtHt50XHabJ

12/09/2025

The AGA-Pfizer Beacon of Hope Awards for Gender and Health Equity are now accepting applications and nominations! Help us honor women in GI who are making a difference. Deadline: Feb. 9. https://ow.ly/ifBU50XGm7k

12/06/2025

Feeling stuck trying to understand what IBD treatments options are available?

Check out the newly launched AGA IBD Drug Guide and explore nearly 60 different IBD treatments so you can work with your care team and make informed decisions about your care.

Start with a short quiz to get personalized treatment recommendations to discuss with your health care provider, then take a deep dive:

🔍 Filter treatments by brand name or generic.
↕️ Sort by safety or efficacy.
💉 See how each drug is taken (oral, injection, infusion).
💊 Browse by drug classes (biologics, TNF blockers, JAK inhibitors, and more).
🧾 Learn about side effects, screening tests, and even alternative drug options (dependent on the type of treatment).

Take control of your IBD journey: https://ow.ly/rhRk50XAV20.

12/04/2025

A new review in Clinical Gastroenterology and Hepatology emphasizes that while steroids can help induce remission, they aren’t effective for long-term maintenance, and extended use can cause significant harm.

Key points:
☑️ Steroids are often overused in IBD care.
☑️ They help with short-term symptom control but not remission maintenance.
☑️ Use should be limited to under two months, serving only as a bridge to safer, targeted therapies.

Read more here:

The American Gastroenterological Association (AGA) is the trusted voice of the GI community. AGA publishes top-tier journals, guidelines and patient education ...

12/02/2025

You’re not alone, IBD warriors and caretakers. 💜 We’re here to support you during Crohn’s and Colitis Awareness Week, and every day.

✨ Introducing the AGA IBD Drug Guide: your one-stop support tool to learn about IBD treatments to make informed decisions about your care.

This brand-new resource is for patients, caretakers, and health care providers – the entirety of the IBD community! Use it as a shared decision-making tool to guide discussions about your treatment plan with your care team.

What you’ll find:

✅ Explore nearly 60 potential treatments that can be filtered by routes of administration (oral, injection, or infusion) by taking a short quiz.
✅ IBD vaccine recommendations
✅ Information about biologics and biosimilars.
…and more resources to support your IBD care!

Get started now: https://ow.ly/7n9s50XAT40.

12/01/2025

For Crohn’s & Colitis Awareness Week (Dec. 1–7), let’s keep the momentum going! Register for the 2026 Crohn’s & Colitis Congress. Take advantage of expert insights, groundbreaking research, and networking opportunities.
✅ Register by Dec. 9 and save
✅ Book your stay at the Bellagio by Dec. 18 for discounted rates
Learn more: https://ow.ly/JwQq50XunPq

11/27/2025

From our table to yours, Happy Thanksgiving from American Gastroenterological Association (AGA)! 🦃🥧

We’re reflecting on this day with gratitude for each of you, and for those behind the scenes at AGA and Digestive Disease Week® (DDW®), many of whom are pictured here during our annual Thanksgiving potluck last week. No matter where you are today, we hope you’re enjoying it with family, friends, or a relaxing activity and meal.

11/26/2025

Do you experience uncomfortable GI symptoms such as having food stuck in your throat, trouble swallowing, or an upset stomach or nausea? During GERD Awareness Week, we’re here to remind you that you’re not alone.

These symptoms impact everyone differently and can lead to different diagnoses. For some people, this can lead to being diagnosed with gastroesophageal reflux disease (GERD).

For others experiencing these symptoms, it could be eosinophilic esophagitis, or EoE, which has similar symptoms. EoE is believed to be caused by an allergic reaction triggered by different foods and causes swelling of the esophagus, which makes it hard to eat and swallow comfortably.

Take the quiz about symptoms associated with EoE to understand where to start your health journey and get connected to resources: https://ow.ly/i78350Xt9yI.